Testing for Pancreatic Cancer
March 7, 2022
Introducing the IMMray® PanCan-d test
Pancreatic cancer is often viewed as a death sentence, primarily because the majority of patients are diagnosed with late-stage disease when surgery is not possible. But if you can detect it early, in stage I or even II, the five-year survival rate improves drastically.
Immunovia’s mission is to improve early detection rates of pancreatic cancer to allow for more and better treatment options. By educating individuals and primary care practitioners about the IMMray® PanCan-d test, they hope to achieve their goal.
The IMMray® PanCan-d test is the first and only blood test dedicated to the early detection of pancreatic cancer. For many, this test signifies hope in a disease that has not provided much hope to people for a long time.
PROMOTED
Celebrate Mother’s Day with The Balancing Act’s exclusive guide, dedicated to creating a day just as special as the moms in our lives. Dive into a treasure trove of activities, delectable recipes, and thoughtful gift ideas curated to make this Mother’s Day an unforgettable celebration of love and appreciation.
PROMOTED
Today's show includes advanced oral care, poverty educational resources, delicious Thai food, funeral planning, and so much more
PROMOTED
Parikh Law Group was founded in 2010 to provide solid, experienced, and affordable representation.
Comments